DC Field | Value | Language |
---|---|---|
dc.contributor.author | Suk Mi Kang-Park | - |
dc.contributor.author | Je Ho Lee | - |
dc.contributor.author | Jeh Hoon Shin | - |
dc.contributor.author | Young Ik Lee | - |
dc.date.accessioned | 2017-04-19T08:57:55Z | - |
dc.date.available | 2017-04-19T08:57:55Z | - |
dc.date.issued | 2001 | - |
dc.identifier.issn | 0006-291X | - |
dc.identifier.uri | 10.1006/bbrc.2001.4767 | ko |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/5445 | - |
dc.description.abstract | We have recently shown that HBx protein, one of the causative agents of hepatocellular carcinomas, regulates Sp1 mediated transcription of insulin-like growth factor II promoter 4 (Lee et al. (1998) Oncogene 16, 2367-2380). Here we show that PKC and p44/p42MAPK signalings are required for the HBx-induced Sp1-mediated IGF-II P4 transcriptional activity since (i) PKC activation by PMA or PKC expression vector increases Sp1 phosphorylation and P4 activity in HBx-transfected HepG2 cells; (ii) PKC inhibition by PKC inhibitor G?6976 reduces Spl phosphorylation, P4 activity, and IGF-II mRNA in HBx-transfected HepG2 cells; and (iii) the inhibition of MEK activation by U0126 reduces Sp1 phosphorylation, P4 activity and IGF-II mRNA in HBx-transfected HepG2 cells. These results demonstrate that PKC and p44/p42 MAPK cascades are the essential signaling pathways in Sp1-mediated IGF-II gene activation by HBx. | - |
dc.publisher | Elsevier | - |
dc.title | Activation of the IGF-II Gene by HBV-X Protein Requires PKC and p44/p42 Map Kinase Signalings | - |
dc.title.alternative | Activation of the IGF-II Gene by HBV-X Protein Requires PKC and p44/p42 Map Kinase Signalings | - |
dc.type | Article | - |
dc.citation.title | Biochemical and Biophysical Research Communications | - |
dc.citation.number | 2 | - |
dc.citation.endPage | 307 | - |
dc.citation.startPage | 303 | - |
dc.citation.volume | 283 | - |
dc.contributor.affiliatedAuthor | Suk Mi Kang-Park | - |
dc.contributor.affiliatedAuthor | Young Ik Lee | - |
dc.contributor.alternativeName | 박숙미 | - |
dc.contributor.alternativeName | 이제호 | - |
dc.contributor.alternativeName | 신재훈 | - |
dc.contributor.alternativeName | 이영익 | - |
dc.identifier.bibliographicCitation | Biochemical and Biophysical Research Communications, vol. 283, no. 2, pp. 303-307 | - |
dc.identifier.doi | 10.1006/bbrc.2001.4767 | - |
dc.subject.keyword | HBV-X | - |
dc.subject.keyword | Hepatocellular carcinomas | - |
dc.subject.keyword | IGF-II | - |
dc.subject.keyword | MAPK | - |
dc.subject.keyword | Phosphorylation | - |
dc.subject.keyword | PKC | - |
dc.subject.keyword | Sp1 | - |
dc.subject.local | HBV-X | - |
dc.subject.local | Hepatocellular carcinoma | - |
dc.subject.local | Hepatocellular carcinoma (HCC) | - |
dc.subject.local | Hepatocellular carcinomas | - |
dc.subject.local | hepatocellular carcinoma | - |
dc.subject.local | hepatocellular carcinoma (HCC) | - |
dc.subject.local | IGF-II | - |
dc.subject.local | MAPK | - |
dc.subject.local | MAPKs | - |
dc.subject.local | Phosphorylation | - |
dc.subject.local | phosphorylation | - |
dc.subject.local | PKC | - |
dc.subject.local | SP-1 | - |
dc.subject.local | SP1 | - |
dc.subject.local | Sp1 | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.